Hi ,
My good friends Ivan and Jonathan have recently launched Dupla Bio, providing low cost, fast turnaround lab space. If you’re interested in setting up a lab for under $60k (office retrofit, warehouse, or greenfield site) then reach out to ivan@dupla.bio. You’ll receive a 10% discount by mentioning SynBioBeta. Dupla is a sponsor of today’s newsletter, I’m an advisor and you can see them in action at SynBioBeta next May in San Jose.
|
 |
Last chance to join our exclusive Boston Biotech Leaders' Breakfast! Join fellow synbio for human health leaders on September 20th for a morning of networking and industry insights. Hear from our expert panel on overcoming manufacturing challenges and navigating regulatory pathways for novel platform therapeutics. Register here →
|
 |
-
A Rallying Call for Synthetic Biology: Challenges, Opportunities, and Future of the Bioeconomy. Here are some reflections to stimulate healthy discussion and refocus our priorities to build more resilient next-generation synthetic biology companies and fully deliver on the bioeconomy.
-
Scala Biodesign Secures Seed Funding to Improve Protein Engineering and Development. Harnessing physics, AI, and biology, Scala offers a groundbreaking approach to protein engineering, promising swifter and more affordable biotech innovations.
-
DNA Biosensor Finds Novel Material for Early Diagnosis of HPV-Related Cancers. Pairing nano-onions or their nanodiamond cousins with various organic biomaterials could revolutionize disease detection.
-
Eco-Friendly Enzymes: Paving the Path to Sustainable Biochemicals. In a ground-breaking study led by the University of Adelaide, researchers have unveiled a revolutionary approach to optimizing plant enzymes through bioengineering.
-
Arzeda Partnership Looks to Revolutionize the Future of Designer Proteins. Arzeda's protein design prowess joins forces with W. L. Gore's advanced materials expertise, heralding a new era in sustainable innovation.
-
Turbocharging RNA Vaccines for a Needle-Free Future. The world of RNA vaccines, which already gave us a good punch against Covid-19, is about to get an upgrade, and it’s a game-changer.
-
E. coli Sparks Change: A Bioelectric Breakthrough in Energy Production. A team of researchers has unveiled a pioneering method to harness E. coli bacteria's innate potential to generate electricity.
|
|
|
|
|
|
|
Other news: |
|
Regards,
John
---
John Cumbers
CEO, SynBioBeta
|
Who's hiring? |
|
|
|
|
|